Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Aug 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1943971000001115 | Sodium hyaluronate 0.4% eye ointment 5 gram | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1943981000001118 | Sodium hyaluronate 0.4% eye ointment 5 gram (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium hyaluronate 0.4% eye ointment 5 gram | Has VMP | Sodium hyaluronate 0.4% eye ointment | true | Inferred relationship | Existential restriction modifier | ||
| Sodium hyaluronate 0.4% eye ointment 5 gram | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Sodium hyaluronate 0.4% eye ointment 5 gram | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Sodium hyaluronate 0.4% eye ointment 5 gram | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Sodium hyaluronate 0.4% eye ointment 5 gram | VMP prescribing status (attribute) | Caution - AMP level prescribing advised | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| eyenite 0.4% eye ointment (Aspire Pharma Ltd) 5 gram | Is a | True | Sodium hyaluronate 0.4% eye ointment 5 gram | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR